Author:
Lentjes E. G. W. M.,Tan Y.,Van Ginneken C. A. M.
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Pharmacology
Reference41 articles.
1. Burns JJ, Yü TF, Ritterband A, Perel JM, Gutman AB, Brodie BB. A potent new uricosuric agent, the sulfoxide metabolite of the phenylbutazone analogue G-25671. J Pharmacol Exp Ther 1957;119:418–26.
2. Pfister B, Imhof P, Wirz H. Effect of sulphinpyrazone (Anturan®) on uric acid excretion and plasma uric acid concentration in healthy volunteers. Eur J Clin Pharmacol 1978;13:263–5.
3. Smythe HA, Ogryzlo MA, Murphy EA, Mustard JF. The effect of sulfinpyrazone (Anturan®) on platelet economy and blood coagulation in man. Can Med Assoc J 1965;92:818–21.
4. Margulies EH, White AM, Sherry S. Sulfinpyrazone: a review of its pharmacological properties and therapeutic use. Drugs 1980;20:179–97.
5. Anturane Reinfarction Trial Research Group. Sulfinpyrazone in the prevention of cardiac death after myocardial infarction. N Engl J Med 1978;298:289–95.
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Renal clearance of sulphinpyrazone in man;European Journal of Clinical Pharmacology;1986-07